BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND DDX6, P54, 1656, ENSG00000110367, HLR2, P26196, RCK, FLJ36338 AND Diagnosis
5 results:

  • 1. [The epidemiological analysis of monitoring of the immune status in liquidators of consequences of the Chernobyl accident for early identification of risk groups and diagnostics of oncological diseases. Report 1].
    Oradovskaia IV; Pashchenkova IuG; Feoktistov VV; Nikonova MF; Vikulov GKh; Bozheskaia NV; Smirnova NN
    Radiats Biol Radioecol; 2011; 51(1):101-16. PubMed ID: 21520622
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence.
    Pettaway CA; Lamerato LE; Eaddy MT; Edwards JK; Hogue SL; Crane MM
    BJU Int; 2011 Oct; 108(8):1302-8. PubMed ID: 21371244
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men.
    Veierød MB; Laake P; Thelle DS
    Int J Cancer; 1997 Nov; 73(5):634-8. PubMed ID: 9398038
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Neoplasms of unknown primary site: a clinicopathological study of autopsied patients.
    Mayordomo JI; Guerra JM; Guijarro C; García-Prats MD; Gómez A; López-Brea M; González R; Hergueta P; López-Pino MA; Martínez-Tello F
    Tumori; 1993 Oct; 79(5):321-4. PubMed ID: 8116074
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
    Ramaekers F; van Niekerk C; Poels L; Schaafsma E; Huijsmans A; Robben H; Schaart G; Vooijs P
    Am J Pathol; 1990 Mar; 136(3):641-55. PubMed ID: 1690512
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.